about
sameAs
An orthostatic hypotension mimic: The inebriation-like syndrome in Parkinson disease.Defining and classifying syncopePrevalence of REM sleep behavior disorder in multiple system atrophy: a multicenter study and meta-analysis.Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival.Treatment of patients with orthostatic hypotension and syncope.Midodrine in neurally mediated syncope: a double-blind, randomized, crossover study.Diagnosis and treatment of neurally mediated syncope.Pharmacological treatment of reflex syncope.Syncope: a clinically guided diagnostic algorithm.Plasma endothelin during upright tilt: relevance for orthostatic hypotension?Enhanced vascular responses to hypocapnia in neurally mediated syncope.Usefulness of tilt-induced heart rate changes in the differential diagnosis of vasovagal syncope and chronic autonomic failure.Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome.Is ambulatory blood pressure monitoring useful in patients with chronic autonomic failure?Droxidopa in neurogenic orthostatic hypotension.Cerebral autoregulation and symptoms of orthostatic hypotension in familial dysautonomia.Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial.Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension.Disturbances in affective touch in hereditary sensory & autonomic neuropathy type III.Droxidopa for neurogenic orthostatic hypotension: a randomized, placebo-controlled, phase 3 trial.Autonomic disorders predicting Parkinson's disease.Cutting the vagal highway blocks one point of entry for prion-like alpha-synuclein.Cognitive impairment in multiple system atrophy: a position statement by the Neuropsychology Task Force of the MDS Multiple System Atrophy (MODIMSA) study group.Randomized withdrawal study of patients with symptomatic neurogenic orthostatic hypotension responsive to droxidopaCurrent treatments in familial dysautonomiaNovel therapeutic approaches in multiple system atrophyVascular endothelial function and blood pressure regulation in afferent autonomic failureOrthostatic hypotension in Parkinson disease: how much you fall or how low you go?Developmental abnormalities, blood pressure variability and renal disease in Riley Day syndromeProgressive retinal structure abnormalities in multiple system atrophy.Increased frequency of rhabdomyolysis in familial dysautonomiaA rating scale for the functional assessment of patients with familial dysautonomia (Riley Day syndrome).Mother-induced hypertension in familial dysautonomiaHyperdopaminergic crises in familial dysautonomia: a randomized trial of carbidopa.Relationship between proprioception at the knee joint and gait ataxia in HSAN III.L-dihydroxyphenylserine (Droxidopa): a new therapy for neurogenic orthostatic hypotension: the US experience.Norepinephrine deficiency with normal blood pressure control in congenital insensitivity to pain with anhidrosisChewing-induced hypertension in afferent baroreflex failure: a sympathetic response?Dexmedetomidine for refractory adrenergic crisis in familial dysautonomia.Natural history of pure autonomic failure: A United States prospective cohort
P50
Q27332878-AAA77760-962F-4061-B740-688601D12060Q28287573-7567C58F-51A6-4703-BE0C-CDD9176C275EQ30642476-2D5F806D-1897-4E4B-BCC2-8959C942B07DQ30714986-878A564E-1F7F-47B8-B9EC-42D9C3960995Q33147719-72CF5196-8A3A-4157-A70D-9C808F829545Q33148062-6CF7D9E9-9F5B-4343-9840-390B18AE7E72Q33149028-FE30C978-FD19-446D-B1C2-E1F3E7BC2183Q33151937-E8504576-8B1C-429B-907F-66B8FEBB9D36Q33151944-7953EC78-700A-41A0-A1DE-F171CD688E71Q33154056-2A22CD3C-C3F2-4FDB-95B7-53DB3A397B39Q33155496-C6887B6B-E951-474B-8979-E43886A8A3EAQ33157944-750C5A3A-E0F6-4C15-9999-D60F421C29F3Q33159812-0F1604AD-0A53-4645-921A-3D070CDF7784Q33164089-32EAF0A5-559E-4AE9-8F9C-D23569069D88Q33165878-FDBFFD7B-C3AE-4FBF-8612-B126D3DA72C7Q33167668-1799167E-CFB4-4DC5-8D51-925B50D17EE2Q33649211-083F3CE4-694E-4526-B50E-AEC79DDDD9B8Q33667809-DDE5C766-F79B-49DA-ABC0-4B4C0AC02E20Q33832702-76AA29C4-6389-4C42-A75F-A29A6C55FAC8Q33972394-081D910A-3438-49C2-9C5F-496C3C4EE0FCQ34004288-5B61B6C1-E1F7-4E18-BCD8-38FAD51D45D3Q34044570-9C4290BA-19BB-4BA2-8AD5-903892FC652BQ34245237-58379391-176A-44E2-94F1-AA75BC6B50DAQ34445249-D09ABE99-C62E-4581-BED5-2DCE4B1B46D0Q34536321-4C18A6AE-8246-415C-AFF8-AC6CB368E154Q34696470-26A22A02-7997-451B-BC32-291F0E6412A2Q35171817-21969D7A-8A4C-4E45-8F4A-60CF3C4E8B72Q35417194-04A7B95D-0EF2-4007-8AFC-AFE0D5F1C7B4Q35868772-18E5763A-5E12-4882-A65D-C5B04F218C55Q36057067-541336D5-6D99-4786-99C3-0B33C2490E30Q36132713-7AD35CCF-A2C8-43FC-8139-6DE0C0336F9EQ36500988-CCFC05F5-11A6-47E0-BC34-490BD0FBE5F0Q36547368-21CEA582-B646-4767-ABB8-CBB797E1AF64Q36870156-A5197A93-4BFE-4093-8C65-C5CC6A48FDA0Q36961525-33937D45-CFAE-4C7C-92F6-03B3A7ADF13BQ37119752-7EB2A505-CA54-41CF-B9F3-DF2ED040A34AQ37357557-4C27E555-CF74-444D-85DB-57D62F083A41Q37357582-C93B8839-CD16-4708-A12A-001D045F8BCBQ37624738-394CDDBF-D0B4-4267-A4C7-4ABDE1591701Q37662455-5DC43C79-A2B5-4F25-A54F-BF820F6ACBBF
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Horacio Kaufmann
@ast
Horacio Kaufmann
@en
Horacio Kaufmann
@es
Horacio Kaufmann
@nl
Horacio Kaufmann
@sl
type
label
Horacio Kaufmann
@ast
Horacio Kaufmann
@en
Horacio Kaufmann
@es
Horacio Kaufmann
@nl
Horacio Kaufmann
@sl
prefLabel
Horacio Kaufmann
@ast
Horacio Kaufmann
@en
Horacio Kaufmann
@es
Horacio Kaufmann
@nl
Horacio Kaufmann
@sl
P106
P21
P31
P496
0000-0002-1851-9981